Yi Zhang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Interstitial Lung Disease

Systemic Sclerosis

Clinical Practice

Epidermal Growth Factor Receptor

Top Venues

Expert opinion on drug safety

Expert review of clinical pharmacology

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Zhuo Ma, Yi Zhang, Ximu Sun, Yuhui Zhang, Min Zhu, Shu Zhang, Xin Feng, Zhuoling An
Anticancer drug-induced interstitial lung disease: a critical appraisal of clinical practice guidelines and consensus statements. Expert opinion on drug safety (2024)
Yi Zhang, Zhuo Ma, Ximu Sun, Yuhui Zhang, Min Zhu, Shu Zhang, Xin Feng, Zhuoling An
Anticancer drug-induced interstitial lung disease: a critical appraisal of clinical practice guidelines and consensus statements. Expert opinion on drug safety (2024)
Yushu Wang, Lihong Liu, Zhuoling An, Yi Zhang, Xin Feng, Xiaojia Yu
Risk of cutaneous adverse events in cancer patients treated with phosphatidylinositol-3-kinase inhibitors: A systematic review and meta-analysis of randomized controlled trials. Cancer medicine (2022)
Lihong Liu, Yi Zhang, Min Zhu, Lin Feng, Yuhui Zhang, Zhuoling An
Interstitial lung disease associated with anti-HER2 anti-body drug conjugates: results from clinical trials and the WHO's pharmacovigilance database. Expert review of clinical pharmacology 15 (11) (2022)